Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Menopausal Hot Flashes Market Size Forecast: How Big Could The Market Get By 2030?
The menopausal hot flashes market size has experienced significant expansion recently. This market is projected to expand from $15.92 billion in 2025 to $16.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.0%. Historically, this growth can be linked to an aging female population, longer life expectancy among women, the extensive application of hormone replacement therapy, increasing recognition of menopausal health, and the development of gynecological healthcare provisions.
The menopausal hot flashes market size is projected to experience robust expansion over the next few years. It is expected to reach $21.68 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5%. The projected increase in this period can be ascribed to a rising demand for safer non-hormonal therapies, the development of menopause-centric healthcare programs, a greater emphasis on women’s health research, the broadening scope of online and digital health consultations, and increasing acceptance of alternative treatment methods. Significant trends for the forecast period include a growing inclination towards non-hormonal treatment alternatives, enhanced awareness and diagnosis of menopausal symptoms, the increasing uptake of alternative and lifestyle-based therapies, the expansion of individualized menopause management strategies, and a higher requirement for long-term symptom management solutions.
Get A Free Sample Report With In-Depth Market Insights:
Menopausal Hot Flashes Market Development Factors: What’s Supporting Demand?
Governmental initiatives focused on women’s health during menopause are projected to stimulate the expansion of the menopausal hot flashes market going forward. These government initiatives for menopausal health involve specific programs, financial allocations, and policy measures intended to enhance care, support research, and broaden access to services for women experiencing symptoms related to menopause. These efforts are on the rise as governments increasingly acknowledge the need for improved education, timely diagnosis, and effective treatment options to aid women’s health throughout the menopausal transition. The menopausal hot flashes market gains from such initiatives by reinforcing research activities, speeding up innovation, and improving the availability of evidence-based treatments for symptom alleviation. For instance, in January 2023, as reported by the Government of New South Wales, an Australia-based government agency, the government committed 0.0403 billion over four years (2022–2023 to 2025–2026) to establish up to 16 new programs designed to support women with severe menopausal symptoms. Therefore, the government’s initiatives for women’s health in menopause are propelling the growth of the menopausal hot flashes market.
Menopausal Hot Flashes Market Segment Performance And Emerging Opportunities
The menopausal hot flashes market covered in this report is segmented –
1) By Type: Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment
2) By Pipeline Analysis: Phase III Drugs, Phase I And II Drugs
3) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies
4) By Application: 51-55 Year Old Woman, 46-50 Year Old Woman, 40-45 Year Old Woman
Subsegments:
1) By Hormonal Treatment: Estrogen Therapy, Combined Hormonal Therapy
2) By Non-Hormonal Treatment: Selective Serotonin Reuptake Inhibitors, Gabapentinoids, Clonidine
3) By Alternative Treatment: Herbal Supplements, Acupuncture, Lifestyle Modifications
Menopausal Hot Flashes Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the global menopausal hot flashes market are focusing on developing innovative therapies, such as non-hormonal neurokinin-3 (NK3) receptor antagonists, to offer safer and more effective treatment options for women who cannot or prefer not to use hormone therapy. Non-hormonal NK3 receptor antagonists are targeted medications that function by blocking neurokinin-3 receptors in the brain’s thermoregulatory center, thereby reducing the frequency and severity of vasomotor symptoms, including moderate to severe hot flashes. For instance, in May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, received Food and Drug Administration (FDA) approval for Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. This medication is the world’s first non-hormonal NK3 receptor antagonist specifically developed for menopausal hot flashes. Veozah provides a novel non-hormonal mechanism of action, once-daily oral dosing, and clinically demonstrated reductions in both the frequency and intensity of vasomotor symptoms, marking a significant advancement for women seeking non-hormonal relief from menopause-related symptoms.
Menopausal Hot Flashes Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the menopausal hot flashes market are Pfizer Inc., Johnson & Johnson, The Procter & Gamble Company, Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Shionogi & Co. Ltd., Gedeon Richter Plc, Lupin Limited, Hisamitsu Pharmaceutical Co. Inc., Noven Pharmaceuticals Inc., Ligand Pharmaceuticals Inc., Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex Ltd., Ascend Therapeutics Inc., EndoCeutics Inc., Sermonix Pharmaceuticals LLC, Ralington pharma LLP
View The Full Menopausal Hot Flashes Market Report:
Menopausal Hot Flashes Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the Menopausal Hot Flashes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopausal hot flashes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
